Moneycontrol PRO
UPCOMING EVENT:Join us for New HorAIzon on Oct-7, 2pm and be a part of exciting conversations on tech & innovation
you are here: HomeNewsBusiness

Eris Lifesciences Q2 PAT seen up 8.5% YoY to Rs 116.9 cr: Prabhudas Lilladher

Net Sales are expected to increase by 11 percent Y-o-Y (up 5.1 percent Q-o-Q) to Rs 361.1 crore, according to Prabhudas Lilladher.

October 06, 2021 / 05:39 PM IST
Eris Lifesciences Ltd.

Eris Lifesciences Ltd.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Prabhudas Lilladher has come out with its second quarter (July-September’ 21) earnings estimates for the Pharma sector. The brokerage house expects Eris Lifesciences to report net profit at Rs 116.9 crore up 8.5% year-on-year (up 9.6% quarter-on-quarter).


Net Sales are expected to increase by 11 percent Y-o-Y (up 5.1 percent Q-o-Q) to Rs 361.1 crore, according to Prabhudas Lilladher.


Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 10 percent Y-o-Y (up 9.2 percent Q-o-Q) to Rs 132.1 crore.


Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Broker Research

stay updated

Get Daily News on your Browser
Sections
ISO 27001 - BSI Assurance Mark